- onset cerebellar ataxia. n engl j med. 2023 ; 388 : 128 – 41. https : / / doi. or validatedprognosticandresponsebiomarkersforscas. g / 1 0. 1 0 5 6 / n e j m o a 2 2 0 7 4 0 6. consequently, further, longitudinal, multimodal biomarker 6. figueroa kp, gross c, buena - atienza e, paul s, gandelman studies are needed. m, kakar n, et al. a ggc - repeat expansion in zfhx3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs acknowledgements not applicable. autophagy. nat genet. 2024 ; 56 : 1080 – 9. https : / / doi. org / 1 0. 1 0 3 8 / s 4 1 5 8 8 - 0 2 4 - 0 1 7 1 9 - 5. author contributions t. k., m. g - e, and j. f. jointly wrote this review 7. ashizawa t, oz g, paulson hl. spinocerebellar ataxias : prospects and challenges for therapy development. nat rev neurol. article. 2018 ; 14 : 590 – 605. https : / / doi. org / 1 0. 1 0 3 8 / s 4 1 5 8 2 - 0 1 8 - 0 0 5 1 - 6. 8. coarelli g, wirth t, tranchant c, koenig m, durr a, anheim funding open access funding enabled and organized by projekt m. the inherited cerebellar ataxias : an update. j neurol. deal. 2023 ; 270 : 208 – 22. https : / / doi. org / 1 0. 1 0 0 7 / s 0 0 4 1 5 - 0 2 2 - 1 1 3 8 3 - 6. not applicable. 9. sequeiros j, martindale j, seneca s, giunti p, kamarainen o, volpini v, et al. emqn best practice guidelines for molecular data availability no datasets were generated or analysed during the genetic testing of scas. eur j hum genet. 2010 ; 18 : 1173 – 6. h t t p current study. s : / / d o i. o